Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

NCT00621244

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center/University of Texas Houston, Texas, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View Trial Details
Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

NCT03352206

Conditions
Elephantiasis, Filarial, Filariasis, Helminthiasis, +11 more
Locations
  • Ministry of Health and Medical Services Suva, Fiji
  • Ministere de la Sante Publique et de la Population Port-au-Prince, Haiti
  • Vector Control Research Centre Puducherry, India
  • Universitas Indonesia Jakarta, Indonesia
View Trial Details
Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

NCT02392611

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Scottsdale, Arizona, United States
  • Fort Wayne, Indiana, United States
  • Goshen, Indiana, United States
  • San Antonio, Texas, United States
View Trial Details

Related conditions